The biomarker CA125 for early detection of ovarian cancer.
STRATEC TO PARTICIPATE IN THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE – Biotech Investments
EQS-News: STRATEC SE / Key word(s): Conference STRATEC TO PARTICIPATE IN THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE 08.01.2025 / 15:18 CET/CEST The issuer is